Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A
Data de publicación
2015Título da revista
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Tipo de contido
Publicación de congreso